Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06655779 · ClinicalTrials.gov registry record
Performance of the Acoustic Based CADScor System in Coronary Artery Disease
A clinical trial, sponsored by INTEGRIS Baptist Medical Center.
- Not yet
- Registry status
- 200
- Enrollment target
NCT06655779: Clinical Trial study, sponsored by INTEGRIS Baptist Medical Center.
NCT06655779 is a clinical trial that has not yet begun recruiting, run by INTEGRIS Baptist Medical Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06655779 has not yet begun recruiting, sponsored by INTEGRIS Baptist Medical Center.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.
Primary Outcome
To determine that the sensitivity of the CAD score in low to intermediate-risk patients referred for coronary CTA in non-inferior to the device specified sensitivity at 89%.
Interventions
- DIAGNOSTIC_TEST Acoustic Detection of Blood Flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-11 |
| Est. Completion | 2026-03 |
What is known before NCT06655779 opens enrollment
NCT06655779 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Acoustic Detection of Blood Flow is the first listed.
NCT06655779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06655779 about?
NCT06655779 is a clinical study titled "Performance of the Acoustic Based CADScor System in Coronary Artery Disease". The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.
What is the current status of trial NCT06655779?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2024-11. Estimated completion is 2026-03.
What interventions are being tested in trial NCT06655779?
The interventions under investigation include: Acoustic Detection of Blood Flow (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06655779?
This trial is sponsored by INTEGRIS Baptist Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia